These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36126365)

  • 21. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes.
    García-Grimshaw M; Posadas-Pinto DR; Jiménez-Ruiz A; Valdés-Ferrer SI; Cadena-Fernández A; Torres-Ruiz JJ; Barrientos-Guerra JD; Amancha-Gabela M; Chiquete E; Flores-Silva FD; Cantú-Brito C
    Lupus; 2022 Feb; 31(2):228-237. PubMed ID: 35042376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of left ventricular strain analysis by cardiovascular magnetic resonance in patients with coronary chronic total occlusion].
    Zhang LJ; Tian JF; Yang XY; Xu L; He Y; Song XT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):601-609. PubMed ID: 34126728
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac abnormalities in antiphospholipid syndrome].
    Meng XM; Zhao Y; Fang LG; Yan XW
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):284-6. PubMed ID: 17637264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.
    Espinosa G; Cervera R
    Nat Rev Rheumatol; 2010 May; 6(5):296-300. PubMed ID: 20386563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study.
    Pontone G; Guaricci AI; Andreini D; Ferro G; Guglielmo M; Baggiano A; Fusini L; Muscogiuri G; Lorenzoni V; Mushtaq S; Conte E; Annoni A; Formenti A; Mancini ME; Carità P; Verdecchia M; Pica S; Fazzari F; Cosentino N; Marenzi G; Rabbat MG; Agostoni P; Bartorelli AL; Pepi M; Masci PG
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29146587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catastrophic antiphospholipid syndrome: a case series.
    Shiber S; Yair M
    Isr Med Assoc J; 2013 Sep; 15(9):481-4. PubMed ID: 24340837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac and cerebral manifestations of antiphospholipid syndrome].
    Jung F; Miesbach W; Scharrer I
    Z Kardiol; 2002 Aug; 91(8):650-8. PubMed ID: 12426829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial Ischaemia, Coronary Atherosclerosis and Pulmonary Pressure Elevation in Antiphospholipid Syndrome Patients.
    Padjas A; Płazak W; Celińska-Lowenhoff M; Mazurek A; Perricone C; Podolec P; Musiał J
    Adv Clin Exp Med; 2016; 25(6):1199-1205. PubMed ID: 28028974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac magnetic resonance imaging features prognostic information in patients with suspected myocardial infarction with non-obstructed coronary arteries.
    Emrich T; Kros M; Schoepf UJ; Geyer M; Mildenberger P; Kloeckner R; Wenzel P; Varga-Szemes A; Düber C; Münzel T; Kreitner KF
    Int J Cardiol; 2021 Mar; 327():223-230. PubMed ID: 33309758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.
    Wong DT; Leung MC; Richardson JD; Puri R; Bertaso AG; Williams K; Meredith IT; Teo KS; Worthley MI; Worthley SG
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1971-81. PubMed ID: 22310980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
    Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.
    Radin M; Schreiber K; Costanzo P; Cecchi I; Roccatello D; Baldovino S; Bazzan M; Cuadrado MJ; Sciascia S
    Int J Cardiol; 2017 Aug; 240():72-77. PubMed ID: 28385357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies.
    El Aidi H; Adams A; Moons KG; Den Ruijter HM; Mali WP; Doevendans PA; Nagel E; Schalla S; Bots ML; Leiner T
    J Am Coll Cardiol; 2014 Mar; 63(11):1031-45. PubMed ID: 24486280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.
    Madison JA; Gockman K; Hoy C; Tambralli A; Zuo Y; Knight JS
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):17. PubMed ID: 35197077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.